Johnson Financial Group Inc (Wisconsin)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.5K | Sell |
95
-55
| -37% | -$10.5K | ﹤0.01% | 564 |
|
|
2026
Q1 | $27.5K | Buy |
150
+35
| +30% | +$6.45K | ﹤0.01% | 535 |
|
|
2025
Q4 | $20.2K | Sell |
115
-4
| -3% | -$653 | ﹤0.01% | 592 |
|
|
2025
Q3 | $16.7K | Buy |
119
+80
| +205% | +$10.8K | ﹤0.01% | 731 |
|
|
2025
Q2 | $4.9K | Hold |
39
| – | – | ﹤0.01% | 642 |
|
|
2025
Q1 | $5.34K | Hold |
39
| – | – | ﹤0.01% | 795 |
|
|
2024
Q4 | $5.61K | Sell |
39
-8
| -17% | -$1.35K | ﹤0.01% | 714 |
|
|
2024
Q3 | $9.11K | Buy |
47
+8
| +21% | +$1.67K | ﹤0.01% | 694 |
|
|
2024
Q2 | $9.04K | Hold |
39
| – | – | ﹤0.01% | 583 |
|
|
2024
Q1 | $8.41K | Sell |
39
-46
| -54% | -$10.8K | ﹤0.01% | 573 |
|
|
2023
Q4 | $22K | Buy |
85
+28
| +49% | +$6.88K | ﹤0.01% | 536 |
|
|
2023
Q3 | $14.7K | Buy |
+57
| New | +$15.2K | ﹤0.01% | 505 |
|
|
2021
Q4 | – | Sell |
-86
| Closed | -$24K | – | 777 |
|
|
2021
Q3 | $24K | Sell |
86
-825
| -91% | -$270K | ﹤0.01% | 485 |
|
|
2021
Q2 | $315K | Buy |
911
+172
| +23% | +$52.1K | 0.02% | 225 |
|
|
2021
Q1 | $207K | Buy |
739
+224
| +43% | +$60.4K | 0.01% | 263 |
|
|
2020
Q4 | $126K | Sell |
515
-318
| -38% | -$82K | 0.01% | 241 |
|
|
2020
Q3 | $236K | Buy |
833
+64
| +8% | +$17.9K | 0.02% | 185 |
|
|
2020
Q2 | $206K | Buy |
769
+40
| +5% | +$12K | 0.02% | 180 |
|
|
2020
Q1 | $231K | Buy |
729
+24
| +3% | +$7.28K | 0.03% | 181 |
|
|
2019
Q4 | $209K | Sell |
705
-203
| -22% | -$56.3K | 0.02% | 205 |
|
|
2019
Q3 | $211K | Buy |
908
+105
| +13% | +$24.4K | 0.02% | 218 |
|
|
2019
Q2 | $188K | Buy |
803
+51
| +7% | +$11.8K | 0.02% | 227 |
|
|
2019
Q1 | $178K | Buy |
752
+64
| +9% | +$20.2K | 0.02% | 223 |
|
|
2018
Q4 | $207K | Buy |
688
+410
| +147% | +$131K | 0.02% | 212 |
|
|
2018
Q3 | $98K | Buy |
278
+17
| +7% | +$5.85K | 0.01% | 268 |
|
|
2018
Q2 | $76K | Sell |
261
-45
| -15% | -$12.7K | 0.01% | 288 |
|
|
2018
Q1 | $84K | Sell |
306
-1,534
| -83% | -$476K | 0.01% | 295 |
|
|
2017
Q4 | $586K | Sell |
1,840
-115
| -6% | -$36.9K | 0.07% | 162 |
|
|
2017
Q3 | $612K | Sell |
1,955
-2,209
| -53% | -$654K | 0.08% | 146 |
|
|
2017
Q2 | $1.13M | Sell |
4,164
-548
| -12% | -$145K | 0.16% | 106 |
|
|
2017
Q1 | $1.29M | Buy |
4,712
+240
| +5% | +$67.9K | 0.16% | 130 |
|
|
2016
Q4 | $1.27M | Buy |
4,472
+728
| +19% | +$216K | 0.18% | 125 |
|
|
2016
Q3 | $1.17M | Buy |
3,744
+992
| +36% | +$294K | 0.16% | 131 |
|
|
2016
Q2 | $665K | Buy |
2,752
+1,256
| +84% | +$331K | 0.09% | 178 |
|
|
2016
Q1 | $389K | Buy |
1,496
+848
| +131% | +$224K | 0.08% | 192 |
|
|
2015
Q4 | $199K | Buy |
648
+464
| +252% | +$133K | 0.04% | 243 |
|
|
2015
Q3 | $53K | Buy |
184
+57
| +45% | +$18.8K | 0.01% | 458 |
|
|
2015
Q2 | $51K | Buy |
127
+34
| +37% | +$13.6K | 0.01% | 486 |
|
|
2015
Q1 | $39K | Buy |
93
+7
| +8% | +$2.76K | 0.01% | 542 |
|
|
2014
Q4 | $29K | Sell |
86
-12
| -12% | -$3.88K | 0.01% | 547 |
|
|
2014
Q3 | $32K | Buy |
98
+49
| +100% | +$16.2K | 0.01% | 502 |
|
|
2014
Q2 | $15K | Hold |
49
| – | – | ﹤0.01% | 567 |
|
|
2014
Q1 | $15K | Sell |
49
-6
| -11% | -$1.91K | ﹤0.01% | 558 |
|
|
2013
Q4 | $15K | Hold |
55
| – | – | ﹤0.01% | 547 |
|
|
2013
Q3 | $13K | Buy |
+55
| New | +$12.3K | ﹤0.01% | 538 |
|
Other funds holding BIIB
Johnson Financial Group Inc (Wisconsin)'s BIIB Position: Q2 2026 in Review
Johnson Financial Group Inc (Wisconsin) reduced its Biogen (BIIB) stake by 37% in Q2 2026, selling an estimated $10.5K and leaving 95 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #564.
Johnson Financial Group Inc (Wisconsin) first reported a position in BIIB in Q3 2013 and has held it in 45 quarters since. The position peaked at $1.29M in Q1 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) held 95 shares of Biogen worth $20.5K as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) sold 55 Biogen shares in Q2 2026, an estimated $10.5K.
- Biogen made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #564 holding.
- Johnson Financial Group Inc (Wisconsin) first reported a position in Biogen in Q3 2013 and has held it in 45 quarters since.
- Johnson Financial Group Inc (Wisconsin)'s Biogen position peaked at $1.29M in Q1 2017.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.